Dipharma Group is a global Contract Development and Manufacturing Organization (CDMO) and a leading manufacturer of Active Pharmaceutical Ingredients and Intermediates for Generic market. 

As part of the global pharmaceutical industry, we serve human health and, therefore, operate to the highest standards of quality and safety with proven experience in handling complex and hazardous processes. 

Founded in 1949, Dipharma is a third-generation family-owned company with an outstanding history of stability, commitment, and financial soundness. 

Dipharma has now expanded its global presence, with more than 500 skilled and highly committed employees, based in Italy, U.S.A. and China, serving over 200 customers in more than 60 countries, including biotech, biopharma and leading pharmaceutical companies. 

Our fully equipped R&D centres, in the U.S.A. and Italy, foster development of robust chemical synthesis, to further secure the manufacturing continuity of the Drug Substance in our 4 cGMP plants. 

Our manufacturing sites are equipped to supply quantities suitable from pre-IND to market, covering the entire lifecycle of a drug. Full compliance with the highest GMP quality standard has been confirmed, since 1970, by an extensive list of successful inspections conducted by major Regulatory Agencies, such as the FDA, Italian Health Authorities and PMDA. 

Dipharma Group has the right size and variety of scale-up capabilities to act as a global player and manage processes efficiently, while offering flexibility and agility to promptly solve any challenge. Experience you can trust.  

Book a meeting with us, in person or online, at https://www.dipharma.com/contacts/ 
We look forward to meeting you in Milan!